Here are six articles Becker's Hospital Review published in the last week, highlighting a spike in blood donors following the mass shooting in Las Vegas and a controversial price gouging law set to take effect in Maryland, among other topics.
1. The ins and outs of mail order pharmacies — How to boost patient convenience without raising costs
As healthcare shifts toward a more consumer-centric approach, some hospitals are developing their own mail order pharmacies to ship prescriptions right to patients' doors.
2. Hundreds line up overnight to donate blood for Las Vegas shooting victims
Hundreds of people lined up outside of Las Vegas blood banks in the hours after a gunman opened fire on the Vegas strip, killing at least 50 people and injuring more than 400.
3. Judge ruling allows drug 'price gouging' law to take effect in Maryland
A U.S. District Court judge denied the generic drug industry trade group's request for a preliminary injunction of Maryland's law that penalizes drugmakers for price gouging —allowing the state law to take effect.
4. FDA commissioner: High drug prices are a 'public health concern the FDA should address'
The FDA will step up efforts to deal with the skyrocketing cost of prescription medicine by encouraging development of "complex" generic drugs, wrote FDA Commissioner Scott Gottlieb, MD, in an Oct. 2 blog post.
5. Physician has been emailing Jeff Bezos for years, urging Amazon to get into healthcare
Over the past few years, Kansas-based family physician Josh Umbehr, MD, has sent dozens of emails to Amazon CEO Jeff Bezos, urging him to direct the company toward the prescription drug market.
6. 4 ways to prepare your supply chain for value-based care
Supply chain performance and efficiency directly affect a healthcare organization's ability to offer quality care. Therefore, the supply chain must transform simultaneously with the healthcare industry amid the shift toward value-based care.
More articles on supply chain:
40 drugs, medical devices at risk of shortages following Hurricane Maria
FDA approves Mylan's generic version of Teva's MS drug
ACLU sues FDA over access to abortion pill: 3 things to know